1 | Note Sheet | 18 Feb 2000 |
10 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 17 Jan 2018 |
11 | Forwarding Letter for TM-6 | 16 Jul 2018 |
12 | Examination Report | 12 Aug 2024 |
2 | Other Documents | 28 Feb 2000 |
3 | TM-1 | 28 Feb 2000 |
4 | Authorization Document (POA) | 18 Apr 2017 |
4 | TM-5 | 26 Sep 2003 |
5 | Annexure | 18 Apr 2017 |
5 | Forwarding Letter for TM-5 | 29 Sep 2003 |
6 | Other Documents | 08 Jan 2004 |
6 | TM-6 | 08 Jan 2004 |
6 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 17 Jan 2018 |
7 | Other Documents | 08 Jan 2004 |
7 | TM-6 | 08 Jan 2004 |
8 | Annexure | 18 Apr 2017 |
8 | Authorization Document (POA) | 18 Apr 2017 |
9 | Annexure | 18 Apr 2017 |
9 | Authorization Document (POA) | 18 Apr 2017 |
The application for Tinibact - n was made on 28 October 1999.
The trademark applicant for Tinibact - n is TORRENT PHARMACEUTICALS.
Tinibact - n is applied in class(es) 5.
Application for Tinibact - n is on Opposed stage.
Application Id allotted to Tinibact - n is 883981.
Trademark agent or attorney for the application is Krishna & Saurastri Associates Llp.
Tinibact - n filed with the Intellectual property office as a WORD.